메뉴 건너뛰기




Volumn 157, Issue 5, 2007, Pages 1058-1060

Arndt-Gottron scleromyxoedema: Successful therapy with intravenous immunoglobulins [11]

Author keywords

Dermatoneuro syndrome; hd IVIg; High dose intravenous immunoglobulin; Monoclonal gammopathy; Scleromyxoedema

Indexed keywords

CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; MELPHALAN; MESNA; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE;

EID: 35348894578     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.08169.x     Document Type: Letter
Times cited : (30)

References (10)
  • 1
    • 85026150241 scopus 로고    scopus 로고
    • Fever, convulsions and coma in scleromyxedema: A 'dermato-neuro syndrome'
    • River Y, Levy I, Gilead L et al. Fever, convulsions and coma in scleromyxedema: a 'dermato-neuro syndrome'. Neurology 1996 46:1778 9.
    • (1996) Neurology , vol.46 , pp. 1778-9
    • River, Y.1    Levy, I.2    Gilead, L.3
  • 2
    • 0346725885 scopus 로고    scopus 로고
    • Scleromyxoedema: Treatment of cutaneous and systemic manifestations with high-dose intravenous immunoglobulin
    • Kulczycki A, Nelson M, Eisen A, Heffernan M. Scleromyxoedema: treatment of cutaneous and systemic manifestations with high-dose intravenous immunoglobulin. Br J Dermatol 2003 149:1276 81.
    • (2003) Br J Dermatol , vol.149 , pp. 1276-81
    • Kulczycki, A.1    Nelson, M.2    Eisen, A.3    Heffernan, M.4
  • 3
    • 0029920574 scopus 로고    scopus 로고
    • Mechanisms of action of intravenous immune globulin in immune-mediated diseases
    • Mouthon L, Kaveri S, Spalter S et al. Mechanisms of action of intravenous immune globulin in immune-mediated diseases. Clin Exp Immunol 1996 104 (Suppl. 1 3 9.
    • (1996) Clin Exp Immunol , vol.104 , Issue.1 , pp. 3-9
    • Mouthon, L.1    Kaveri, S.2    Spalter, S.3
  • 4
    • 0033898132 scopus 로고    scopus 로고
    • Scleromyxedema: Response to high-dose intravenous immunoglobulin (hdIVIg)
    • Lister RK, Jolles S, Whittaker S et al. Scleromyxedema: response to high-dose intravenous immunoglobulin (hdIVIg). J Am Acad Dermatol 2000 43:403 8.
    • (2000) J Am Acad Dermatol , vol.43 , pp. 403-8
    • Lister, R.K.1    Jolles, S.2    Whittaker, S.3
  • 5
    • 19944427764 scopus 로고    scopus 로고
    • Effectiveness of intravenous immunoglobulin therapy for skin disease other than toxic epidermal necrolysis: A retrospective review of Mayo Clinic experience
    • Wetter DA, Davis MD, Yiannias JA et al. Effectiveness of intravenous immunoglobulin therapy for skin disease other than toxic epidermal necrolysis: a retrospective review of Mayo Clinic experience. Mayo Clin Proc 2005 80:41 7.
    • (2005) Mayo Clin Proc , vol.80 , pp. 41-7
    • Wetter, D.A.1    Davis, M.D.2    Yiannias, J.A.3
  • 6
    • 21744447373 scopus 로고    scopus 로고
    • Tumorous variant of scleromyxedema. Successful therapy with intravenous immunoglobulins
    • Wojas-Pelc A, Blaszczyk M, Glinska M et al. Tumorous variant of scleromyxedema. Successful therapy with intravenous immunoglobulins. J Eur Acad Dermatol Venereol 2005 19:462 5.
    • (2005) J Eur Acad Dermatol Venereol , vol.19 , pp. 462-5
    • Wojas-Pelc, A.1    Blaszczyk, M.2    Glinska, M.3
  • 7
    • 33645853200 scopus 로고    scopus 로고
    • Combination oral prednisone and intravenous immunoglobulin in the treatment of scleromyxedema
    • Majeski C, Taher M, Grewal P et al. Combination oral prednisone and intravenous immunoglobulin in the treatment of scleromyxedema. J Cutan Med Surg 2005 9:99 104.
    • (2005) J Cutan Med Surg , vol.9 , pp. 99-104
    • Majeski, C.1    Taher, M.2    Grewal, P.3
  • 8
    • 0036145088 scopus 로고    scopus 로고
    • Intravenous immunoglobulins control scleromyxoedema
    • Righi A, Schiavon F, Jablonska S et al. Intravenous immunoglobulins control scleromyxoedema. Ann Rheum Dis 2002 61:59 61.
    • (2002) Ann Rheum Dis , vol.61 , pp. 59-61
    • Righi, A.1    Schiavon, F.2    Jablonska, S.3
  • 9
    • 2442689242 scopus 로고    scopus 로고
    • Successful treatment of scleromyxoedema with high dose intravenous immunoglobulin
    • Karim A, Lawlor F, Black MM. Successful treatment of scleromyxoedema with high dose intravenous immunoglobulin. Clin Exp Dermatol 2004 29:317 18.
    • (2004) Clin Exp Dermatol , vol.29 , pp. 317-18
    • Karim, A.1    Lawlor, F.2    Black, M.M.3
  • 10
    • 34250321375 scopus 로고    scopus 로고
    • [Marked improvement in scleromyxedema with high-dose intravenous immunoglobulin]
    • Topf S, Simon M Jr., Schell H et al. [Marked improvement in scleromyxedema with high-dose intravenous immunoglobulin]. Hautarzt 2007 58:525 8.
    • (2007) Hautarzt , vol.58 , pp. 525-8
    • Topf, S.1    Simon Jr., M.2    Schell, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.